According to this latest study, the 2021 growth of Rapid Antigen Testing will have significant change from previous year. By the most conservative estimates of global Rapid Antigen Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Rapid Antigen Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Antigen Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Immunosorbent Assay
Enzyme-linked Immunosorbent
Precipitation Reaction
Radioimmunoassay
Agglutination Reaction
Complement Fixatio

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospitals
Specialty Clinics
Diagnostic Centers
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
F. Hoffmann-La Roche
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
Sino Biological
R-Biopharma
Cell Biolabs
Thermo Fisher Scientific
Bio-Rad Laboratories